College of Medical Science, Three Gorges University, Yichang 443002, China.
Curr Pharm Des. 2021;27(46):4699-4706. doi: 10.2174/1381612827666210927105558.
It is substantiated that LncRNAs are associated with carcinoma progression. OIP5- AS1 is a tumor-related carcinoma suppressor lncRNA, previously discovered in zebrafish, which is involved in the progression of a variety of cancers, has a regulatory effect on carcinoma, and interacts with miRNA and other biomolecules to affect the physiological and pathological processes of carcinoma cells. This article will discuss the effect of OIP5-AS1 in various cancers and its regulatory mechanism.
This paper summarized and analyzed OIP5-AS1, which functions on the germination and progression of carcinoma and its regulatory mechanism. Meanwhile, the related research was retrieved and collected by the PubMed system.
OIP5-AS1 is overexpressed in various tumors, which regulates and controls tumor growth and participates in tumor progression, including breast carcinoma, ovarian carcinoma, cervical carcinoma, lung carcinoma, laryngeal squamous cell gastric carcinoma and hepatocellular carcinoma. The research evidence proves that OIP5-AS1 takes part in carcinoma proliferation, growth, migration, invasion, and apoptosis.
OIP5-AS1 probably can be an effective biomarker or a potential therapeutic target in multiple tumors.
长链非编码 RNA 与癌症的进展有关。OIP5-AS1 是一种肿瘤相关的抑癌长链非编码 RNA,最初在斑马鱼中发现,它参与多种癌症的进展,对癌症具有调节作用,并与 miRNA 和其他生物分子相互作用,影响癌细胞的生理和病理过程。本文将讨论 OIP5-AS1 在各种癌症中的作用及其调控机制。
本文通过总结和分析 OIP5-AS1 在癌症发生和发展中的作用及其调控机制,同时通过 PubMed 系统检索和收集相关研究。
OIP5-AS1 在多种肿瘤中表达上调,调节和控制肿瘤的生长并参与肿瘤的进展,包括乳腺癌、卵巢癌、宫颈癌、肺癌、喉鳞状细胞癌和肝癌。研究证据表明,OIP5-AS1 参与了癌细胞的增殖、生长、迁移、侵袭和凋亡。
OIP5-AS1 可能是多种肿瘤的有效生物标志物或潜在治疗靶点。